No Effect of One-Year Treatment with Indomethacin on Alzheimer's Disease Progression: A Randomized Controlled Trial

• Daniëlle de Jong ,

  *To whom correspondence should be addressed. E-mail: d.dejong@neuro.umcn.nl

  Affiliations Department of Neurology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands, Department of Geriatric Medicine, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

  ⨯
• René Jansen,

  Affiliations Department of Geriatric Medicine, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands, Alzheimer Center Nijmegen, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

  ⨯
• Willibrord Hoefnagels,

  Affiliations Department of Geriatric Medicine, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands, Alzheimer Center Nijmegen, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

  ⨯
• Marja Jellesma-Eggenkamp,

  Affiliation Department of Geriatric Medicine, Rijnstate Hospital, Arnhem, The Netherlands

  ⨯
• Marcel Verbeek,

  Affiliations Department of Neurology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands, Alzheimer Center Nijmegen, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands, Laboratory of Pediatrics and Neurology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

  ⨯
• George Borm,

  Affiliation Department of Epidemiology and Biostatistics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

  ⨯
• Berry Kremer

  Affiliation Department of Neurology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands

  ⨯